Business Description
United Laboratories International Holdings Ltd
ISIN : KYG8813K1085
Total Employee Number:
18,000Compare
Compare
Traded in other countries / regions
03933.Hong KongUNJ.GermanyULIHF.USA IPO Date
2021-07-22Description
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Finished products segment, followed by Bulk medicine. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.13 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.29 | |||||
Debt-to-EBITDA | 1.55 | |||||
Interest Coverage | 35.37 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.2 | |||||
Beneish M-Score | -2.9 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.6 | |||||
3-Year EBITDA Growth Rate | 5.5 | |||||
3-Year EPS without NRI Growth Rate | 5.3 | |||||
3-Year FCF Growth Rate | -12.3 | |||||
3-Year Book Growth Rate | 14.3 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 3.42 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 57.41 | |||||
9-Day RSI | 58.22 | |||||
14-Day RSI | 56.43 | |||||
3-1 Month Momentum % | -15.6 | |||||
6-1 Month Momentum % | -26.98 | |||||
12-1 Month Momentum % | -39.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.83 | |||||
Quick Ratio | 1.6 | |||||
Cash Ratio | 1.05 | |||||
Days Inventory | 118.64 | |||||
Days Sales Outstanding | 62.64 | |||||
Days Payable | 240.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 5.32 | |||||
Dividend Payout Ratio | 0.42 | |||||
3-Year Dividend Growth Rate | 49.1 | |||||
Forward Dividend Yield % | 5.32 | |||||
5-Year Yield-on-Cost % | 34.22 | |||||
3-Year Average Share Buyback Ratio | -2.8 | |||||
Shareholder Yield % | -20.97 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 41.68 | |||||
Operating Margin % | 18.73 | |||||
Net Margin % | 15.73 | |||||
EBITDA Margin % | 24.51 | |||||
FCF Margin % | 6.48 | |||||
OCF Margin % | 28.39 | |||||
ROE % | 13.27 | |||||
ROA % | 7.29 | |||||
ROIC % | 15.11 | |||||
3-Year ROIIC % | 6.27 | |||||
ROC (Joel Greenblatt) % | 24.19 | |||||
ROCE % | 13.58 | |||||
Years of Profitability over Past 10-Year | 9 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 7.54 | |||||
Forward PE Ratio | 9.24 | |||||
PE Ratio without NRI | 8.06 | |||||
Shiller PE Ratio | 12.23 | |||||
Price-to-Owner-Earnings | 5.48 | |||||
PEG Ratio | 0.54 | |||||
PS Ratio | 1.18 | |||||
PB Ratio | 0.94 | |||||
Price-to-Tangible-Book | 0.97 | |||||
Price-to-Free-Cash-Flow | 18.59 | |||||
Price-to-Operating-Cash-Flow | 4.18 | |||||
EV-to-EBIT | 4.15 | |||||
EV-to-Forward-EBIT | 5.64 | |||||
EV-to-EBITDA | 3.32 | |||||
EV-to-Forward-EBITDA | 4.7 | |||||
EV-to-Revenue | 0.81 | |||||
EV-to-Forward-Revenue | 0.74 | |||||
EV-to-FCF | 12.32 | |||||
Price-to-GF-Value | 1.07 | |||||
Price-to-Projected-FCF | 0.56 | |||||
Price-to-DCF (Earnings Based) | 0.34 | |||||
Price-to-DCF (FCF Based) | 1.6 | |||||
Price-to-Median-PS-Value | 1.13 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.54 | |||||
Price-to-Graham-Number | 0.59 | |||||
| Price-to-Net-Current-Asset-Value | 3.32 | |||||
Earnings Yield (Greenblatt) % | 24.1 | |||||
FCF Yield % | 5.18 | |||||
Forward Rate of Return (Yacktman) % | 22.19 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
United Laboratories International Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,598.004 | ||
| EPS (TTM) (€) | 0.134 | ||
| Beta | -0.0675 | ||
| 3-Year Sharpe Ratio | 0.3 | ||
| 3-Year Sortino Ratio | 0.48 | ||
| Volatility % | 30.97 | ||
| 14-Day RSI | 56.43 | ||
| 14-Day ATR (€) | 0.036996 | ||
| 20-Day SMA (€) | 0.9495 | ||
| 12-1 Month Momentum % | -39.47 | ||
| 52-Week Range (€) | 0.865 - 1.86 | ||
| Shares Outstanding (Mil) | 1,970.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
United Laboratories International Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
United Laboratories International Holdings Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| HKD 0.299034 Cash Dividend | 2026-07-07 | 1.06 (+0.00%) | ||
| HKD 0.175070 Cash Dividend | 2025-09-25 | 1.59 (+0.00%) | ||
| HKD 0.131393 Cash Dividend | 2025-07-08 | 1.66 (+5.73%) | ||
| HKD 0.306585 Cash Dividend | 2025-07-08 | 1.66 (+5.73%) | ||
| HKD 0.176315 Cash Dividend | 2024-09-19 | 0.95 (+0.00%) |
Show
Entries
United Laboratories International Holdings Ltd Frequently Asked Questions
What is United Laboratories International Holdings Ltd(STU:UNJ)'s stock price today?
The current price of STU:UNJ is €1.00. The 52 week high of STU:UNJ is €1.86 and 52 week low is €0.87.
When is next earnings date of United Laboratories International Holdings Ltd(STU:UNJ)?
The next earnings date of United Laboratories International Holdings Ltd(STU:UNJ) is .
Does United Laboratories International Holdings Ltd(STU:UNJ) pay dividends? If so, how much?
The Dividend Yield %  of United Laboratories International Holdings Ltd(STU:UNJ) is 5.32% (As of Today), Highest Dividend Payout Ratio of United Laboratories International Holdings Ltd(STU:UNJ) was 0.43. The lowest was 0.13. And the median was 0.18. The  Forward Dividend Yield % of United Laboratories International Holdings Ltd(STU:UNJ) is 5.32%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on United Laboratories International Holdings Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers